Cargando…
The potential use of thalidomide in the therapy of graft-versus-host disease—A review of clinical and laboratory information
This article reviews the historical development of thalidomide as an immunosuppressive agent and the current state of knowledge of thalidomide as an anti-graft-versus-host disease (GVHD) agent. The evidence suggests that metabolites of thalidomide act at an early stage in the antigen recognition-act...
Autores principales: | Wood, Philip M.D., Proctor, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133718/ https://www.ncbi.nlm.nih.gov/pubmed/2189044 http://dx.doi.org/10.1016/0145-2126(90)90024-4 |
Ejemplares similares
-
Thalidomide—Then and Now: Case Report of a Woman With Thalidomide Embryopathy and Review of Current Thalidomide Uses
por: Malik, Sara, et al.
Publicado: (2021) -
Therapy of Angiosarcoma with Thalidomide and Lenalidomide
por: Mattes, M. Jules, et al.
Publicado: (2021) -
Ruxolitinib for Therapy of Graft-versus-Host Disease
por: Neumann, Thomas, et al.
Publicado: (2019) -
Potential of TCR sequencing in graft-versus-host disease
por: Goel, Manisha, et al.
Publicado: (2022) -
Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity
por: Grkovic, Lana, et al.
Publicado: (2011)